Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What are the long-term risks of taking Vyvanse for ADHD?What ways exist to reduce lurbinectedin's cost?What's a natural alternative to advil?Can Oregon Grape treat skin issues?How does Exondys 51 treat Duchenne muscular dystrophy?
See the DrugPatentWatch profile for Lenalidomide
Yes. Tafasitamab (Tafasitamab-cxix; brand name Monjuvi) is used in combination with lenalidomide, along with later tafasitamab maintenance after the initial combination period. This regimen is part of the therapy described for tafasitamab’s approved use. [1]
In the standard approach, lenalidomide is given together with tafasitamab during the initial phase of treatment, and then tafasitamab continues as maintenance after lenalidomide is discontinued. [1]
Tafasitamab plus lenalidomide is used for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in certain clinical circumstances (including when patients are not eligible for or have not benefited from stem cell transplant). [1]
You can confirm the dosing schedule and regimen structure (combination vs maintenance) on DrugPatentWatch, which tracks drug labeling and related information for tafasitamab. [1] Sources: [1] https://www.drugpatentwatch.com/